#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11782	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2070	555.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1756	1756	T	655	T	621	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	11782	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2070	555.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1490	1490	C	634	C	618	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22078	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3308	653.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1526	1526	A	680	A	650	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22078	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3308	653.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2160	2160	C	638	C	612	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22078	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3308	653.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2234	2234	A	676	A	657	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	22078	23S	2890	2890	99.93	23S.l15.c17.ctg.1	3308	653.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	2786	2786	C	699	C,T	670,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
blaTEM.WHO_M_pConjugative_00003	blaTEM.WHO_M_pConjugative_00003	1	0	27	35704	blaTEM	861	861	100.0	blaTEM.l15.c17.ctg.1	1626	2160.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Betalactam resistance
folP.WHO_L_00516	folP.WHO_L_00516	1	1	539	1516	folP	855	855	99.88	folP.l15.c30.ctg.1	1840	81.3	1	SNP	p	R229S	1	R229S	NONSYN	685	687	CGC	1148	1150	AGC	130;132;130	A;G;C	124;128;125	folP.WHO_L_00516:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4740	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3379	138.1	0	.	p	.	0	D95A	NONSYN	283	285	GAC	655	657	GCC	146;144;144	G;C;C	144;144;141	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4740	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3379	138.1	1	SNP	p	S91F	1	.	.	271	273	TTC	643	645	TTC	148;148;149	T;T;C,T	142;142;142,1	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1336	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1390	94.5	0	.	p	.	0	A39T	NONSYN	115	117	GCC	477	479	ACC	153;152;152	A,C;C;C	141,1;147;147	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1336	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1390	94.5	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	675	677	CAC	179;177;176	C,T;A;C	174,1;168;173	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1336	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1390	94.5	0	.	p	.	0	A127fs	FSHIFT	379	379	G	741	741	G	157	GCCCC,GCC	150,1	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	531	1336	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1390	94.5	1	SNP	p	G45D	0	.	.	133	135	GGC	495	497	GGC	163;162;161	G;G;C	154;154;152	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	760	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	934	79.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3850	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2830	133.8	0	.	p	.	0	S87N	NONSYN	259	261	AGT	524	526	AAT	132;130;132	A;A,C;T	125;125,1;125	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3850	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2830	133.8	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1568	1570	GCA	166;165;160	G,T;C,T;A,G	151,1;147,1;146,1	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3850	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2830	133.8	1	SNP	p	D86N	0	.	.	256	258	GAC	521	523	GAC	130;131;131	G;A;C	124;122;125	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	3850	parC	2304	2304	99.7	parC.l15.c17.ctg.1	2830	133.8	1	SNP	p	S88P	0	.	.	262	264	TCC	527	529	TCC	132;132;129	T;C;C	129;127;126	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3298	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2502	129.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1452	1454	GGC	165;162;159	G;G;C	161;158;155	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	A311V	0	.	.	931	933	GCA	1337	1339	GCA	174;178;178	G;C;A	163;167;169	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	I312M	0	.	.	934	936	ATC	1340	1342	ATC	177;176;174	A;T;C	170;166;164	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	V316T	0	.	.	946	948	GTG	1352	1354	GTG	176;176;177	G;T;G	168;164;171	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	V316P	0	.	.	946	948	GTG	1352	1354	GTG	176;176;177	G;T;G	168;164;171	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1856	1858	ACC	151;152;153	A;C;C	142;145;146	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1910	1912	GCG	145;141;141	G;C;G	137;122;134	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1910	1912	GCG	145;141;141	G;C;G	137;122;134	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2033	2035	GGT	119;117;116	G;G;T	113;111;108	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2042	2044	GGC	114;113;112	G;G,A;C	107;106,1;106	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3112	penA	1752	1752	100.0	penA.l6.c30.ctg.1	2381	128.2	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2060	2062	CCG	106;109;108	C,G;C,G;G	82,2;90,1;86	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	4412	ponA	2397	2397	100.0	ponA.l15.c30.ctg.1	3158	137.1	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1595	1597	CCG	152;154;152	C;C;G	136;141;138	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2002	porA	1146	1146	99.65	porA.l6.c4.ctg.1	1669	116.8	0	.	p	.	0	M83fs	FSHIFT	247	247	A	502	502	C	118	C,A	115,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	0	.	p	.	0	E134K	NONSYN	400	402	GAG	617	619	AAG	181;181;180	A;A;G	171;171;170	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	0	.	p	.	0	R143G	NONSYN	427	429	AGA	644	646	GGA	172;169;174	G;G;A	159;159;163	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	0	.	p	.	0	.	INDELS	629	630	AA	847	849	TAG	166;167;166	T,A;A;G,A	161,1;162;154,1	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	0	.	p	.	0	.	MULTIPLE	631	633	TAC	851	854	CAAT	164;164;164;168	C;A;A;T	157;160;160;162	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	0	.	p	.	0	N212fs	FSHIFT	634	634	A	856	856	T	170	T	164	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	1	SNP	p	G120K	0	.	.	358	360	GGT	575	577	GGT	157;160;159	G;G;T,G	150;154;147,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	1	SNP	p	A121N	0	.	.	361	363	GCC	578	580	GCC	158;157;156	G,T;C;C	154,1;154;155	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2142	porB1b	1035	1035	98.75	porB1b.l15.c30.ctg.1	1403	149.7	1	SNP	p	A121D	0	.	.	361	363	GCC	578	580	GCC	158;157;156	G,T;C;C	154,1;154;155	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	7628	rpoB	4179	4179	99.98	rpoB.l6.c30.ctg.1	4911	152.7	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2019	2021	AAT	158;156;159	A;A;T	155;154;157	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	792	rpsJ	312	312	100.0	rpsJ.l15.c30.ctg.1	936	83.3	1	SNP	p	V57M	1	.	.	169	171	ATG	474	476	ATG	147;145;145	A;T;G	140;139;137	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	M177T	NONSYN	529	531	ATG	817	819	ACG	376;373;381	A;C;G	364;364;371	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	838	840	GAC	365;367;370	G;A;C	363;361;367	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	T190M	NONSYN	568	570	ACG	856	858	ATG	352;352;349	A;T;G	345;347;343	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	L194S	NONSYN	580	582	TTA	868	870	TCA	351;349;346	T;C;A	346;345;343	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	913	915	CAG	337;334;335	C;A;G	335;332;334	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	V216L	NONSYN	646	648	GTT	934	936	CTT	311;306;304	C;T;T	311;305;304	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	N223S	NONSYN	667	669	AAC	955	957	AGT	281;286;294	A;G,T;T	279;281,1;287	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1024	1026	CCG	389;390;395	C;C;G	375;376;382	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1126	1128	TCG	486;486;485	T;C;G	463;463;466	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1297	1299	AAA	264;263;264	A;A;A	254;255;255	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1300	1302	AAG	263;259;260	A;A;G	255;252;252	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1315	1317	CAC	226;230;228	C;A,C;C	224;222,1;226	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1354	1356	GAA	235;232;238	G;A,T;A	233;230,1;236	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1432	1434	ACG	136;135;135	A;C;G	136;135;134	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1483	1485	ATT	203;202;200	A;T;T	199;198;196	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1486	1488	AGT	198;198;197	A;G;T	194;194;191	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1525	1527	CTA	233;232;235	C;T;A	225;224;228	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1567	1569	AAT	173;171;173	A;A;T	170;169;171	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1636	1638	TCA	224;224;228	T;C;A	223;221;219	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1660	1662	ATG	243;243;247	A;T;G	238;238;241	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	1954	1956	ACC	504;505;508	A,G;C;C,T,A	478,1;486;490,1,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9540	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2624	357.8	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2050	2052	GAA	500;501;501	G;A;A,T	480;481;482,1	.	Tetracycline resistance
